These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22683782)

  • 1. Effect of serum proteins on an exogenous pulmonary surfactant: ESR analysis of structural changes and their relation with surfactant activity.
    Martínez Sarrasague M; Cimato A; Rubin de Celis E; Facorro G
    Respir Physiol Neurobiol; 2012 Jul; 183(1):48-57. PubMed ID: 22683782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum lipoproteins and cholesterol on an exogenous pulmonary surfactant. ESR analysis of structural changes and their relation with surfactant activity.
    Martínez Sarrasague M; Cimato A; Piehl L; Brites F; Facorro G
    Respir Physiol Neurobiol; 2013 Dec; 189(3):581-7. PubMed ID: 23994827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of serum protein and albumin addition on the structure and activity of an exogenous pulmonary surfactant.
    Martínez Sarrasague M; Cimato A; Rubin de Celis E; Facorro G
    Respir Physiol Neurobiol; 2011 Mar; 175(3):316-21. PubMed ID: 21185407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the fluid ordered and disordered phases in a pulmonary surfactant by electron spin resonance technique.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2020 Jan; 271():103309. PubMed ID: 31561012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids.
    Cimato A; Hoyos Obando A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2016 Nov; 233():33-40. PubMed ID: 27476933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant subtypes. In vitro conversion, in vivo function, and effects of serum proteins.
    Ueda T; Ikegami M; Jobe A
    Am J Respir Crit Care Med; 1994 May; 149(5):1254-9. PubMed ID: 8173767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
    Serrano AG; Pérez-Gil J
    Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between plasma proteins and pulmonary surfactant: surface balance studies.
    Keough KM; Parsons CS; Phang PT; Tweeddale MG
    Can J Physiol Pharmacol; 1988 Sep; 66(9):1166-73. PubMed ID: 2464426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical studies on the interaction of serum albumin with pulmonary surfactant extract in films and bulk bilayer phase.
    Nag K; Vidyashankar S; Devraj R; Fritzen Garcia M; Panda AK
    J Colloid Interface Sci; 2010 Dec; 352(2):456-64. PubMed ID: 20850129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholesterol on the physical properties of pulmonary surfactant films: atomic force measurements study.
    Leonenko Z; Finot E; Vassiliev V; Amrein M
    Ultramicroscopy; 2006; 106(8-9):687-94. PubMed ID: 16675117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2018 Jan; 247():80-86. PubMed ID: 28963086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary surfactant proteins insert cation-permeable channels in planar bilayers.
    Oelberg DG; Xu F
    Mol Genet Metab; 2000 Aug; 70(4):295-300. PubMed ID: 10993716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term ozone exposure affects the surface activity of pulmonary surfactant.
    Putman E; Liese W; Voorhout WF; van Bree L; van Golde LM; Haagsman HP
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):288-96. PubMed ID: 9070351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical surface potential of pulmonary surfactant.
    Leonenko Z; Rodenstein M; Döhner J; Eng LM; Amrein M
    Langmuir; 2006 Nov; 22(24):10135-9. PubMed ID: 17107011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the main components of blood on pulmonary surfactant].
    Serebrovskaia IA; Biul' EV; Baimanova KhM; Karpuk VI; Vakhrushev BN
    Biull Eksp Biol Med; 1979 Dec; 88(12):648-50. PubMed ID: 583256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An X-ray diffraction study of alterations in bovine lung surfactant bilayer structures induced by albumin.
    Larsson M; Nylander T; Keough KM; Nag K
    Chem Phys Lipids; 2006; 144(2):137-45. PubMed ID: 17055468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural models and surface equation of state for pulmonary surfactant monolayers.
    Zeng Z; Li D; Xue W; Sun L
    Biophys Chem; 2007 Dec; 131(1-3):88-95. PubMed ID: 17976898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.
    Hohlfeld JM; Schmiedl A; Erpenbeck VJ; Venge P; Krug N
    J Allergy Clin Immunol; 2004 Mar; 113(3):496-502. PubMed ID: 15007353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.